CN Patent

CN106074414B — 一种含有鲁拉西酮的口腔崩解片及其制备方法

Assigned to CHENGDU KANGHONG PHARMACEUTICALS GROUP Co Ltd · Expires 2019-01-18 · 7y expired

What this patent protects

本发明涉及一种含有盐酸鲁拉西酮的口腔崩解片及其制备方法，本发明的口腔崩解片含有盐酸鲁拉西酮、填充剂、崩解剂、矫味剂和润滑剂，同时控制盐酸鲁拉西酮的粒径D 90 ≤75μm，本发明的盐酸鲁拉西酮口腔崩解片具有很好的体外溶出度以及良好的口感；本发明的口腔崩解片制剂工艺简单，采用常规制粒及压片设备即可实现工业化大生产。

USPTO Abstract

本发明涉及一种含有盐酸鲁拉西酮的口腔崩解片及其制备方法，本发明的口腔崩解片含有盐酸鲁拉西酮、填充剂、崩解剂、矫味剂和润滑剂，同时控制盐酸鲁拉西酮的粒径D 90 ≤75μm，本发明的盐酸鲁拉西酮口腔崩解片具有很好的体外溶出度以及良好的口感；本发明的口腔崩解片制剂工艺简单，采用常规制粒及压片设备即可实现工业化大生产。

Drugs covered by this patent

lurasidone-hydrochloride (LURASIDONE HYDROCHLORIDE)

Patent Metadata

Patent number: CN106074414B
Jurisdiction: CN
Classification: —
Expires: 2019-01-18
Drug substance claim: No
Drug product claim: No
Assignee: CHENGDU KANGHONG PHARMACEUTICALS GROUP Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.